Skip to content

Drug interactions

Tolvaptan + Tucatinib

Severity: Major

Tolvaptan and Tucatinib: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Tucatinib is a strong CYP3A inhibitor and may substantially increase tolvaptan exposure. This raises the risk of excessive aquaresis, dehydration and overly rapid correction of sodium.

What this interaction means in plain words

Tolvaptan and Tucatinib can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Tolvaptan belongs to Endocrine; Tucatinib belongs to Oncology.

Evidence level: Moderate

Why it happens

Inhibition of CYP3A4 decreases tolvaptan clearance.

What to do

Avoid the combination if possible. If unavoidable, reduce the tolvaptan dose per labeling and monitor serum sodium and fluid status closely.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Tolvaptan and Tucatinib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Tolvaptan with Tucatinib?

MediHelp rates the interaction as major. Tolvaptan and Tucatinib can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Tucatinib is a strong CYP3A inhibitor and may substantially increase tolvaptan exposure. This raises the risk of excessive aquaresis, dehydration and overly rapid correction of sodium.

How serious is the interaction between Tolvaptan and Tucatinib?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid the combination if possible. If unavoidable, reduce the tolvaptan dose per labeling and monitor serum sodium and fluid status closely.

What other medicines interact with Tolvaptan?

MediHelp also lists interactions of Tolvaptan with, for example, Atazanavir, Ceritinib, Cobicistat. The full list is on the Tolvaptan page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in